James E. Flynn - Possible Member of 10% Group, 10%+ Owner at Xilio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Possible Member of 10% Group, 10%+ Owner
Stock Symbol
XLO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James E. Flynn since 9/17/2023

Holdings reported by James E. Flynn for Xilio Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.14M $949K $0.83 Oct 26, 2021 Through Deerfield Partners, L.P.
Common Stock 1.14M $949K $0.83 Oct 26, 2021 Through Deerfield Private Design Fund V, L.P.
Series C Preferred Stock 0 Oct 26, 2021 Through Deerfield Partners, L.P. Common Stock
Series C Preferred Stock 0 Oct 26, 2021 Through Deerfield Private Design Fund V, L.P. Common Stock

Transactions reported by James E. Flynn for Xilio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.